Biological therapy in patients with Rheumatoid arthritis

Abstract

The foundation of modern biological therapy have significantly changed the whole system of treatment of rheumatic diseases, is the use of antagonists of tumor necrosis factor alpha (TNF-α). Drugs of this class are most relevant concepts of "disease-control" means, as to significantly reduce the direct manifestation of the disease and significantly inhibit joint destruction, leading to the development of disease remission with previously unattainable speed.